Ketamine inhibition of SARS-CoV-2 replication in astrocytes is associated with COVID-19 disease severity in a variant-dependent manner
Borut Furlani, Maja Potokar, Miša Korva, Katarina Resman Rus, Patricija Pozvek, Tomaž Mark Zorec, Julijan Vrsnik, Samo Pirnat, Petra Tavčar Verdev, Tina Smolič, Anemari Horvat, Kristina Radinovic, Nina Grasselli Kmet, Tatjana Avšič‐Županc, Nina Vardjan, , Robert Zorec
The paper investigates how ketamine affects SARS-CoV-2 replication in astrocytes and its association with COVID-19 severity, finding variant-dependent inhibition effects.
bioRxiv · Mar 29, 2025 · PreprintNeuroscience